Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03384563 · ClinicalTrials.gov registry record · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
A Phase 4 study of Pediatric Anesthesia, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT03384563: Recruiting Phase 4 study of Pediatric Anesthesia, sponsored by Baylor College of Medicine.
NCT03384563 is a Phase 4 study of Pediatric Anesthesia that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 180 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03384563, a Phase 4 study of Pediatric Anesthesia, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.
Primary Outcome
The study is completed after assessment of patient movement with skin incision
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-02-18 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
What NCT03384563 shows while recruiting
NCT03384563 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Pediatric Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT03384563 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03384563 about?
NCT03384563 is a clinical study titled "Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane". The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.
What is the current status of trial NCT03384563?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2018-02-18. Estimated completion is 2025-12-31.
What conditions does trial NCT03384563 study?
This clinical trial studies the following conditions: Pediatric Anesthesia.
What interventions are being tested in trial NCT03384563?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT03384563?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03384563 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03384563's enrollment target sits among peer trials
180 466th of 2000 higher than 1,526 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
- NCT03610763 · 180 participants · NA
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI